A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors (vol 31, pg 742, 2013)

作者:Shapiro Geoffrey I; McCallum Stewart; Adams Laurel M*; Sherman Laurie; Weller Steve; Swann Suzanne; Keer Harold; Miles Dale; Mueller Thomas; Rabe Daniel C; Cecchi Fabiola; Bottaro Donald P; LoRusso Patricia
来源:Investigational New Drugs, 2015, 33(6): 1292-1292.
DOI:10.1007/s10637-015-0287-6
  • 出版日期2015-12

全文